Nadia Waheed, M.D.

Nadia Waheed, M.D.

Chief Medical OfficeratOcular Therapeutix· In the 2025 proxy

Pay in FY2025Ocular Therapeutix stock +42.2% the same year

Nadia Waheed, M.D. was paid $4.4M in FY2025 (Dec). Ocular Therapeutix stock rose 42.2% that year.

Pay$100 in the stock at the end of FY24 → $142
Pay is from the Summary Compensation Table of each Ocular Therapeutix proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Ocular TherapeutixPublic company · 1 yr
    • Chief Medical Officer2025 – Present · 1 yrStock in role -12%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

Two people shown as one, or a wrong number?